Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Bernstein Initiates Coverage On Koninklijke Ahold Delhaiz with Outperform Rating

Bernstein initiates coverage on Koninklijke Ahold Delhaiz (OTC:ADRNY) with a Outperform rating.
byBenzinga Newsdesk
July 8, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Bernstein initiates coverage on Koninklijke Ahold Delhaiz (OTC:ADRNY) with a Outperform rating.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Ligand’s Partner Merck Receives FDA Approval for VAXNEUVANCE For The Prevention of Invasive Pneumococcal Disease in Adults Caused by 15 Serotypes; Under The Terms Of The Licensing Agreement With Merck, Ligand Earned A $2M Milestone Payment

By Benzinga Newsdesk
Today, 6:05 AM
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced that its partner Merck has received approval from the U.S. Food and Drug Administration (FDA) for VAXNEUVANCETM, also known as V114, for the prevention of

LGND